IP Library › Granted Patent US 8,734,375
Granted Patent B2
US 8,734,375 · App. 12/599,254 · Granted May 27, 2014

Blood treatment method adapted to at least partially eliminate the carbon dioxide content and related device

Inventors: Antonio Maria Pesenti (Milan, IT); Nicolò Antonino Patroniti (Milan, IT)
Assignee: Universitá degli Studi di Milano-Bicocca
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,734,375
App. No.
12/599,254
Granted
May 27, 2014
Kind
B2
Abstract

A blood treatment method is described that is adapted to at least partially eliminate the carbon dioxide content of the type comprising a step of drawing a blood flow. Advantageously according to the invention, the method further comprises the steps of: acidifying the blood flow with transformation of the related blood bicarbonate content into gaseous carbon dioxide; and eliminating the gaseous carbon dioxide content by means of a pressure gradient.

Claims (27)

1. A blood treatment method adapted to at least partially eliminate the carbon dioxide content comprising the steps of:

drawing a blood flow from a patient;

acidifying said blood flow by inserting an acid load to cause transformation of the related blood bicarbonate content into gaseous carbon dioxide;

eliminating said gaseous carbon dioxide content by means of a pressure gradient; and

removing said acid load from said acidified blood flow, with obtainment of a treated blood flow, and

returning said treated blood flow to the patient,

wherein the acid load inserted into the blood flow comprises a mixture of an inorganic acid and organic acids and wherein said acidification step comprises a simultaneous step of ventilating said blood flow through an artificial membrane lung, in turn comprising a step of oxygenating said blood flow.

2. The blood treatment method according to claim 1 , wherein said step of inserting said acid load provides for an inflow of a mixture of organic and inorganic acids in various proportions and total amount.

3. The blood treatment method according to claim 1 , further comprising a step of filtering said blood flow and wherein said acidification step is achieved on an ultrafiltrate thus obtained.

4. The blood treatment method according to claim 3 , wherein it provides for a step of pumping said ultrafiltrate.

5. The blood treatment method according to claim 1 , further comprising a step of recirculating said blood flow in a feedback path, with inflow of a treated blood portion to said blood flow immediately before said acidification and ventilation step.

6. The blood treatment method according to claim 5 , further comprising a step of recirculating said blood flow in a feedback path, with inflow of a blood portion that has been treated and further acidified immediately before its ventilation.

7. The blood treatment method according to claim 1 , wherein said step of removing said acid load from said treated blood flow comprises a hydroelectrolytic rebalancing step.

8. The blood treatment method according to claim 7 , wherein said hydroelectrolytic rebalancing step comprises one of the following methods:

direct haemodialysis of said treated blood flow;

filtration of said treated blood flow with obtainment of an ultrafiltrate and elimination of an ultrafiltrate amount such to compensate for said inserted acid load, with subsequent infusion of a basic load amount;

balancing, via dialysis, of an ultrafiltrate with a batch liquid subjected to desalination, with subsequent infusion of a basic load amount; or

balancing of an ultrafiltrate via electrodialysis or diffusion dialysis with net removal of the added acid load and possible reutilization of the same for blood acidification.

9. The blood treatment method according to claim 1 , wherein it comprises more than one blood acidification step with an inflow of several acid loads.

10. The blood treatment method according to claim 1 , wherein it comprises several blood ventilation steps.

11. The blood treatment method according to claim 1 , further comprising a step of pumping said blood flow.

12. The blood treatment method according to claim 1 , wherein the inorganic acid is hydrochloric acid (HCl).

13. The blood treatment method according to claim 1 , wherein the organic acids are selected from pyruvic acid, citric acid, and lactic acid.

14. The blood treatment method according to claim 1 , wherein the acid mixture is inserted into the blood flow in an amount of less than about 25 mMol/liter.

15. The blood treatment method according to claim 1 , wherein the acid mixture is inserted into the blood flow at a rate of 0-10 mMol/min.

16. The blood treatment method according to claim 1 , comprising bringing the gaseous carbon dioxide pressure and the pH to nearly normal values.

17. The blood treatment method according to claim 1 , comprising bringing the partial pressure of gaseous carbon dioxide to greater than 450 mmHg.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2017
From: UNIVERSITÁ DEGLI STUDI DI MILANO-BICOCCA
To: XENIOS AG
Reel/Frame 044073/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2010
From: PESENTI, ANTONIO MARIA; PATRONITI, NICOLO ANTONINO
To: UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA
Reel/Frame 023898/0056 →
Priority Claims (1)
IT MI2007A0913 · May 7, 2007 · national
Continuity (1)
Related Publication 20100198132A1 · Aug 5, 2010